AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 239 filers reported holding AMICUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $582 | +2.3% | 47,841 | +5.5% | 0.00% | 0.0% |
Q2 2023 | $569 | +41.9% | 45,341 | +25.5% | 0.00% | +50.0% |
Q1 2023 | $401 | -9.1% | 36,141 | 0.0% | 0.00% | -33.3% |
Q4 2022 | $441 | -99.9% | 36,141 | +21.1% | 0.00% | +50.0% |
Q3 2022 | $312,000 | -39.5% | 29,841 | -37.9% | 0.00% | -33.3% |
Q2 2022 | $516,000 | +10.7% | 48,041 | -2.4% | 0.00% | 0.0% |
Q1 2022 | $466,000 | -18.1% | 49,241 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $569,000 | +21.1% | 49,241 | 0.0% | 0.00% | +50.0% |
Q3 2021 | $470,000 | -1.1% | 49,241 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $475,000 | -2.5% | 49,241 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $487,000 | -57.2% | 49,241 | 0.0% | 0.00% | -57.1% |
Q4 2020 | $1,137,000 | +63.6% | 49,241 | 0.0% | 0.01% | +40.0% |
Q3 2020 | $695,000 | -53.2% | 49,241 | -50.0% | 0.01% | -16.7% |
Q2 2020 | $1,486,000 | – | 98,482 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |